The National Association for Proton Therapy’s Annual Member Survey showed more patients treated, additional centers opening, and an evolving and complex case mix of disease sites being treated with proton therapy.
Huntsman Cancer Institute at the University of Utah signed a contract with Mevion Medical Systems for a second MEVION S250i Proton Therapy System, doubling treatment capacity and broadening access to patients with a wide range of cancers, including pediatric, head and neck, and breast cancers.
